absorptive cell

Absorption into the intestinal absorptive cells is not the end.

Chylomicrons are created by the absorptive cells of the small intestine, known as enterocytes.

The brush border morphology increases a cell's surface area, a trait which is especially useful in absorptive cells.

Retinol enters the absorptive cells of the small intestine, preferentially in the all-trans-retinol form.

It is synthesized in the absorptive cells of the small intestine from polyglutamylated dietary folate.

In the disease process, C. perfringens penetrates the upper jejunum between absorptive cells and releases beta toxin.

Enterocytes, or intestinal absorptive cells, are simple columnar epithelial cells found in the small intestines and colon.

FGF15 is found in the absorptive cells of the mouse ileum and plays an important role in feedback inhibition of hepatic bile acid synthesis.

In areas of intestinal metaplasia, gap junctions were occasionally seen between absorptive cells of the villi, but not in the lateral membranes of goblet cells.

It provides additional surface for adsorption and includes enzymes secreted by the absorptive cells that are essential for the final steps of digestion of proteins and sugars.

It creates a meshwork 0.3 micrometers thick and consists of acidic mucopolysaccharides and glycoproteins that project from the apical plasma membrane of epithelial absorptive cells.

Chylomicrons are a type of structure that includes lipoprotein produced in absorptive cells of small intestines, specifically, the epithelial cells within the villi of the duodenum.

Once the virus infects the host, it multiplies in the cell lining of the small intestine resulting in the loss of absorptive cells that in turn leads to shortening of villi.

Tight binding of carrageenan to ingested food proteins is considered less available than in drinking water for interaction with the absorptive cells of the GI tract, although some studies have linked food-grade carrageenan to gastrointestinal disease in laboratory animals, including ulcerative colitis-like disease, intestinal lesions, and ulcerations.